Press Release Nanoscope Therapeutics to Participate in the 28th Annual H.C. Wainwright Global Investment Conference 2 hours ago
Press Release Nanoscope Therapeutics Announces U.S. Food and Drug Administration Acceptance of Biologics License Application for MOGENRY for the Treatment of Retinitis Pigmentosa with Severe Vision Loss Sep 9